BioCentury
ARTICLE | Company News

Celgene, Receptos both rise after deal

July 16, 2015 1:19 AM UTC

Celgene Corp. (NASDAQ:CELG) and Receptos Inc. (NASDAQ:RCPT) each posted gains on Wednesday, a day after Celgene said it will acquire Receptos for $232 per share, or $7.2 billion net of Receptos' cash (see BioCentury Extra, July 14). ...